Lab Groups Disagree With GAO That Medicare Will Be Overbilled For PAMA Test Payments
Executive Summary
A coalition of US laboratories and diagnostic test-makers say it strongly disagrees with GAO’s conclusions that labs will be overbilling Medicare for future payments under the “Protecting Access To Medicare Act of 2014”, and sent a letter to GAO managers last week arguing its case.
You may also be interested in...
New US State And Proposed Federal Laws Would Stop Specialists From Balance Billing
A crop of new US consumer protection state laws and proposed federal legislation is aimed at stopping medical specialists from the practice of balance billing.
Medicare Planning To Pay Too Much For Lab Services? Grassley And GAO Say 'Yes'
Senate Finance Committee Chairman Chuck Grassley says Medicare would be overpaying for laboratory tests if it goes forward with its planned increases to diagnostic prices on the Medicare Clinical Lab Fee Schedule (CLFS). Industry groups disagree.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.